Skip to main content
JOHNSON & JOHNSON logo

JOHNSON & JOHNSON — Investor Relations & Filings

Ticker · JNJ ISIN · US4781601046 LEI · 549300G0CFPGEF6X2043 US Manufacturing
Open in API
Filings indexed 3,105 across all filing types
Latest filing 2018-04-30 Director's Dealing
Country US United States of America
Listing US JNJ

About JOHNSON & JOHNSON

https://www.jnj.com/

Johnson & Johnson is a healthcare company that operates through two primary segments: Innovative Medicine and MedTech. The Innovative Medicine division is focused on the research, development, and delivery of new treatments for complex diseases in areas such as oncology, immunology, neuroscience, and cardiopulmonary conditions. The MedTech segment develops and provides a broad portfolio of medical technologies and solutions. It innovates in fields including surgery, orthopaedics, vision, and interventional solutions, aiming to create smarter, less invasive, and more personalized healthcare treatments. The company's mission is to address significant health challenges through science-based innovation at the intersection of biology and technology.

Recent filings

Filing Released Lang Actions
Director's Dealing 2018
Director's Dealing
2018-04-30 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 26, 2018, reporting the results of the company's annual shareholder meeting. It includes detailed voting results on director elections, executive compensation advisory votes, ratification of the auditor, and shareholder proposals. Additionally, it announces a dividend increase. The content is focused on the submission of matters to a vote of security holders and the official voting results. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length is about 5974 characters, which is sufficient to contain detailed voting results rather than just an announcement of a report. Therefore, the correct classification is DVA with high confidence.
2018-04-30 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 17, 2018, reporting on the results of operations and financial condition for the first quarter ended April 1, 2018. It includes a press release announcing sales and earnings and supplementary sales data and condensed consolidated statement of earnings. The document is a current report providing updates on financial results and restructuring plans, typical of an 8-K filing. It is not a full annual or quarterly report but an initial announcement of quarterly financial results and related operational updates. Therefore, it fits the definition of an Earnings Release (ER). The document length is 4284 characters, which is consistent with a brief earnings announcement rather than a full report.
2018-04-17 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is used for current reports on significant events. The content specifically announces the retirement of the CFO and the appointment of a new CFO, detailing management changes. There are no financial statements or detailed financial data presented. The document length is 3360 characters, which is relatively short and focused on management changes. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). Therefore, this document is best classified as MANG.
2018-03-20 English
Director's Dealing 2018
Director's Dealing
2018-03-15 English
Director's Dealing 2018
Director's Dealing
2018-03-15 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.